.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cantor Fitzgerald
McKinsey
Harvard Business School
Cerilliant
Fuji
Farmers Insurance
Argus Health
US Army
Chubb

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,680,312

« Back to Dashboard

Summary for Patent: 4,680,312

Title: Stable prostaglandin E gels utilizing colloidal silicon dioxide as a gel-forming agent
Abstract:The present invention provides an improved class of stable gels of prostaglandin E compounds prepared from solutions of prostaglandin E compounds in a pharmaceutically acceptable, stabilizing organic solvent, e.g., triacetin, gelled by the addition of colloidal silicon dioxide.
Inventor(s): Johnson; Brian S. (Crawley, GB)
Assignee: The Upjohn Company (Kalamazoo, MI)
Application Number:06/674,357
Patent Claim Types:
see list of patent claims
Dosage form;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,680,312

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8208322Mar 22, 1982

International Patent Family for Patent: 4,680,312

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany3381898► Subscribe
Denmark127883► Subscribe
Denmark167139► Subscribe
European Patent Office0089768► Subscribe
Finland81962► Subscribe
Finland830890► Subscribe
Hong Kong91993► Subscribe
JapanH0322850► Subscribe
JapanS58167509► Subscribe
Norway163042► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Johnson and Johnson
Mallinckrodt
Express Scripts
Julphar
Colorcon
Fuji
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot